Kestra Medical Technologies, Ltd.
KMTS
$16.55
-$0.42-2.48%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 115.05% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 115.05% | -- | -- | -- | |
| Cost of Revenue | 29.70% | -- | -- | -- | |
| Gross Profit | 6,587.85% | -- | -- | -- | |
| SG&A Expenses | 64.35% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 47.23% | -- | -- | -- | |
| Operating Income | -25.06% | -- | -- | -- | |
| Income Before Tax | -20.81% | -- | -- | -- | |
| Income Tax Expenses | 462.50% | -- | -- | -- | |
| Earnings from Continuing Operations | -20.92% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -20.92% | -- | -- | -- | |
| EBIT | -25.06% | -- | -- | -- | |
| EBITDA | -33.89% | -- | -- | -- | |
| EPS Basic | 13.22% | -- | -- | -- | |
| Normalized Basic EPS | 15.78% | -- | -- | -- | |
| EPS Diluted | 13.22% | -- | -- | -- | |
| Normalized Diluted EPS | 15.78% | -- | -- | -- | |
| Average Basic Shares Outstanding | 11.75% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 11.75% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |